U.S. flag

An official website of the United States government

NM_000363.5(TNNI3):c.204del (p.Arg69fs) AND Cardiomyopathy

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
May 18, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001526043.4

Allele description [Variation Report for NM_000363.5(TNNI3):c.204del (p.Arg69fs)]

NM_000363.5(TNNI3):c.204del (p.Arg69fs)

Gene:
TNNI3:troponin I3, cardiac type [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
19q13.42
Genomic location:
Preferred name:
NM_000363.5(TNNI3):c.204del (p.Arg69fs)
Other names:
p..R69AfsX8
HGVS:
  • NC_000019.10:g.55156280del
  • NC_000019.9:g.55667647del
  • NG_007866.2:g.6454del
  • NM_000363.5:c.204delMANE SELECT
  • NP_000354.4:p.Arg69fs
  • LRG_432t1:c.204del
  • LRG_432:g.6454del
  • NC_000019.9:g.55667647del
  • NC_000019.9:g.55667647delC
  • NC_000019.9:g.55667648del
  • NM_000363.4:c.204del
  • NM_000363.4:c.204delG
  • NM_000363.5:c.204delGMANE SELECT
  • p.Arg69AlafsX8
Protein change:
R69fs
Links:
dbSNP: rs727504872
NCBI 1000 Genomes Browser:
rs727504872
Molecular consequence:
  • NM_000363.5:c.204del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Cardiomyopathy (CMYO)
Synonyms:
Cardiomyopathies
Identifiers:
MONDO: MONDO:0004994; MedGen: C0878544; Human Phenotype Ontology: HP:0001638

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001736312Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(May 18, 2023)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

SCV004239768CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(May 17, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A fast and cost-effective molecular diagnostic tool for genetic diseases involved in sudden cardiac death.

Chanavat V, Janin A, Millat G.

Clin Chim Acta. 2016 Jan 30;453:80-5. doi: 10.1016/j.cca.2015.12.011. Epub 2015 Dec 10.

PubMed [citation]
PMID:
26688388

Targeted panel sequencing in pediatric primary cardiomyopathy supports a critical role of TNNI3.

Kühnisch J, Herbst C, Al-Wakeel-Marquard N, Dartsch J, Holtgrewe M, Baban A, Mearini G, Hardt J, Kolokotronis K, Gerull B, Carrier L, Beule D, Schubert S, Messroghli D, Degener F, Berger F, Klaassen S.

Clin Genet. 2019 Dec;96(6):549-559. doi: 10.1111/cge.13645. Epub 2019 Oct 22.

PubMed [citation]
PMID:
31568572
See all PubMed Citations (7)

Details of each submission

From Color Diagnostics, LLC DBA Color Health, SCV001736312.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

This variant deletes 1 nucleotide in exon 5 of the TNNI3 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. An experimental functional study using heart tissue from a homozygous individual affected with dilated cardiomyopathy has shown that TNNI3 protein was not expressed in heart tissue (PMID: 31568572). This variant has been reported in homozygosity in multiple individuals affected with early-onset dilated cardiomyopathy (PMID: 31568572, 35050212, 36981019); heterozygous carrier parents were either not clinically affected or were not fully clinically evaluated for TNNI3-related disorders. This variant has also been reported in heterozygosity in an individual affected with dilated cardiomyopathy (PMID: 36129056), in unclear zygosity in another individual affected with dilated cardiomyopathy (PMID: 34286374), and in an individual affected with cardiomyopathy or arrhythmia (PMID: 26688388). This variant has been identified in 9/236002 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Clinical relevance of loss-of-function TNNI3 truncation variants in autosomal dominant cardiovascular disorders is not clearly established. The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario, SCV004239768.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 6, 2024